PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
🔒 Subscribers only
AUTH/2885/11/16
Off-label Promotion Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Gedeon Richter
An anonymous (non-contactable) complainant, describing themselves as a senior obstetrics & gynaecology doctor, complained about an Esmya (ulipristal acetate) patient support leaflet (ref UK/ESM…
Clauses: 9.1,9.2
🔒 Subscribers only
AUTH/2903/11/16
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Novo Nordisk
The PMCPA Director initiated a complaint after a CMRO publication (25 Nov 2016) assessed disclosure of results for company-sponsored trials linked to new medicines approved by EMA in 2013.The publi…
Clauses: NONE
🔒 Subscribers only
AUTH/2884/10/16
Data & Publications Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Intrapharm
A CCG medicines management team member complained about a letter Intrapharm sent to GP practices in the named CCG (ref ccf-222-001), copied to the PMCPA.The letter was headed “New Carbocisteine i…
Clauses: 9.1,9.2
🔒 Subscribers only
AUTH/2923/12/16
Off-label Promotion Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Merck Sharp & Dohme
A hospital pharmacist complained about a two-page Remicade (infliximab) advertisement by Merck Sharp & Dohme, published in The Pharmaceutical Journal (Oct–Dec 2016).Page 1 featured an intact …
Clauses: NONE
🔒 Subscribers only
AUTH/2825/3/16
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Janssen v Boehringer Ingelheim & Lilly
Janssen-Cilag complained about a two-sided A4 “Dear UK Healthcare Professional” letter (ref UK/EMP/00241) about Jardiance (empagliflozin) cardiovascular outcomes.The letter was stapled to a rep…
Clauses: NONE
🔒 Subscribers only
AUTH/2831/4/16
HCP Hospitality & Meetings Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Celgene
Celgene made a voluntary admission after an internal alert that a promotional meeting invitation for Otezla (apremilast) had been sent to a Celgene employee’s personal email address (the employee…
Clauses: NONE
🔒 Subscribers only
AUTH/2821/2/16
HCP Hospitality & Meetings Upheld 🏥 Other ▶ Video 🎙 Podcast
Sanofi Genzyme
Sanofi Genzyme voluntarily admitted inviting members of patient organisations to the Biotech Industry Association (BIA) gala dinners in 2014 and 2015 and providing hospitality where there was no sc…
Clauses: 22.1,22.2
🔒 Subscribers only
AUTH/2819/2/16
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Otsuka
A general practitioner complained that Jinarc (tolvaptan) patient support materials portrayed the medicine as a treatment for ADPKD, amounting to advertising to the public and risking raised patien…
Clauses: NONE
🔒 Subscribers only
AUTH/2818/1/16
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Pfizer
A head of medicines and prescribing at a clinical commissioning group (CCG) complained about an email sent by a third party event organiser to another CCG staff member.The email subject was: “Und…
Clauses: NONE
🔒 Subscribers only
AUTH/2824/2/16
HCP Hospitality & Meetings Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Chiesi
An anonymous complainant alleged a regional business manager (RBM) and a new account executive visited customers in a named location before they were fully trained/validated and compliant on Chiesi…
Clauses: NONE
🔒 Subscribers only
AUTH/2827/3/16
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Novartis
An anonymous hepatologist complained about a Novartis tweet relating to liver disease.The complaint was received on 10 March 2016.The case was completed on 13 April 2016.
Clauses: NONE
🔒 Subscribers only
AUTH/2858/7/16
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Bayer
A complaint was made by a health professional against Bayer.The allegation was “promotion to the public”.Case reference: AUTH/2858/7/16.Complaint received: 26 July 2016.
Clauses: NONE
🔒 Subscribers only
AUTH/2881/10/16
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Shire
An anonymous complainant (non-contactable) alleged there was a Shire video on a public website.The complaint was received on 11 October 2016.
Clauses: NONE
🔒 Subscribers only
AUTH/2891/11/16
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Astellas
An ex-employee made a complaint about Astellas.The case topic is listed as “Certification and review of materials”.The PMCPA considered the matter under the ABPI Code process.
Clauses: NONE
🔒 Subscribers only
AUTH/2894/11/16
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Mitsubishi Tanabe
A complaint was brought by the Director against Mitsubishi Tanabe.The subject matter related to clinical trial disclosure for BindRen.The case was completed on the same date it was received.
Clauses: NONE
🔒 Subscribers only
AUTH/2895/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Boehringer Ingelheim
A complaint was brought by the Director against Boehringer Ingelheim.The subject matter related to clinical trial disclosure for Giotrif.Complaint received: 06 December 2016.
Clauses: NONE
🔒 Subscribers only
AUTH/2896/11/16
Data & Publications Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Janssen
A complaint was considered under case AUTH/2896/11/16.The case related to clinical trial disclosure for Invokana.The complainant was the Director (PMCPA).Company: Janssen.
Clauses: NONE
🔒 Subscribers only
AUTH/2899/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Aegerion
A matter was raised by the PMCPA Director regarding clinical trial disclosure relating to Lojuxta.The case was considered under the PMCPA complaints process.
Clauses: NONE
🔒 Subscribers only
AUTH/2900/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Sanofi
The PMCPA Director raised a complaint against Sanofi concerning clinical trial disclosure relating to Lyxumia and Zaltrap.The matter was considered under case numbers AUTH/2900/11/16 and AUTH/2910/…
Clauses: NONE
🔒 Subscribers only
AUTH/2904/11/16
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Lundbeck
A matter was considered by the PMCPA involving the Director and Lundbeck.The case related to clinical trial disclosure for Selincro.Complaint received: 06 December 2016.
Clauses: NONE
🔒 Subscribers only
AUTH/2905/11/16
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
A Menarini
A complaint was considered under case number AUTH/2905/11/16.The complainant was the Director (PMCPA).The respondent company was A Menarini.The PMCPA assessed whether the matter fell within the sco…
Clauses: NONE
🔒 Subscribers only
AUTH/2907/11/16
Data & Publications Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Takeda
A matter was considered by the PMCPA involving the Director and Takeda.The case related to clinical trial disclosure for Vipidia.Complaint received: 06 December 2016.
Clauses: NONE
🔒 Subscribers only
AUTH/2909/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Astellas UK
The Director raised a complaint against Astellas UK.The issue related to clinical trial disclosure concerning Xtandi.The case was recorded as completed on the same date it was received.
Clauses: NONE
🔒 Subscribers only
AUTH/2846/5/16
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
Janssen
Janssen voluntarily admitted that a first-line sales manager did not take the required ABPI representatives examination within one year of starting the role.The employee moved into the sales manage…
Clauses: 11.2
← Prev 32 33 34 35 36 37 38 Next → Page 35 of 73 — 1752 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews